Compare NVAX & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | ATLC |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1996 | 2009 |
| Metric | NVAX | ATLC |
|---|---|---|
| Price | $8.05 | $81.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $14.11 | ★ $127.40 |
| AVG Volume (30 Days) | ★ 5.8M | 110.3K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | 24.95 |
| EPS | N/A | ★ 9.62 |
| Revenue | $1,123,479,000.00 | ★ $1,968,399,000.00 |
| Revenue This Year | N/A | $440.35 |
| Revenue Next Year | N/A | $12.87 |
| P/E Ratio | ★ N/A | $8.67 |
| Revenue Growth | ★ 64.69 | 50.09 |
| 52 Week Low | $6.20 | $47.50 |
| 52 Week High | $13.39 | $114.34 |
| Indicator | NVAX | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 34.94 | 40.07 |
| Support Level | $7.48 | $74.19 |
| Resistance Level | $10.64 | $94.35 |
| Average True Range (ATR) | 0.71 | 5.82 |
| MACD | -0.23 | -1.22 |
| Stochastic Oscillator | 1.09 | 12.14 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.